Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma

Overview of attention for article published in Frontiers in Neuroscience, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 81,169 followers.

Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in #meningioma https://t.co/KtlYhDRwfH

19 Dec 2022

Reply Repost Favourite

RT @FrontNeurosci: New Research: Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in m…

14 Dec 2022

Reply Repost Favourite

New Research: Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma: Background Enhancer of zeste homolog 2 (EZH2), an important epigenetic regulator, that mainly regulates… https://t.co/upAa93

13 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.